Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

nihon generic co.,ltd - lanthanum carbonate hydrate - white to faint yellowish white granules

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - dantron 5 mg/ml; poloxamer 188 40 mg/ml - oral suspension - active: dantron 5 mg/ml poloxamer 188 40 mg/ml excipient: aluminium magnesium silicate citric acid monohydrate ethanol peach ni flavour (qz04060) glyceryl mono-oleate hyetellose monobasic sodium phosphate dihydrate potassium sorbate propylene glycol saccharin sodium sodium propyl hydroxybenzoate as nipasept sorbitol water

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - dantron 15 mg/ml; poloxamer 188 200 mg/ml - oral suspension - active: dantron 15 mg/ml poloxamer 188 200 mg/ml excipient: aluminium magnesium silicate citric acid monohydrate ethanol peach ni flavour (qz04060) capsicine natural (qz01070) glyceryl mono-oleate monobasic sodium phosphate dihydrate potassium sorbate propylene glycol saccharin sodium sodium propyl hydroxybenzoate as nipasept sorbitol water

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - dantron 5 mg/ml; poloxamer 188 40 mg/ml - oral suspension - 5mg/40mg/ml - active: dantron 5 mg/ml poloxamer 188 40 mg/ml excipient: aluminium magnesium silicate citric acid peach 403788 peach n30 nipasept; sodium salts of methyl, ethyl, propyl paraben potassium sorbate propylene glycol alginate purified water saccharin sodium sorbitol xanthan gum

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - dantron 15 mg/ml; poloxamer 188 200 mg/ml - oral suspension - 15/200mg/ml - active: dantron 15 mg/ml poloxamer 188 200 mg/ml excipient: aluminium magnesium silicate citric acid peach 403788 peach n30 nipasept; sodium salts of methyl, ethyl, propyl paraben potassium sorbate propylene glycol alginate purified water saccharin sodium sorbitol xanthan gum

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

procter & gamble pharmaceuticals - dantrolene sodium (unii: 287m0347ev) (dantrolene - unii:f64qu97qcr) - capsule - in chronic spasticity: dantrium is indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. if improvement occurs, it will ordinarily occur within the dosage titration (see dosage and administration ), and will be manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrium. occasionally, subtle but meaningful improvement in spasticity may occur with dantrium therapy. in such instances, information regarding improvement should be solicited from the patien

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dantrolene sodium hemiheptahydrate 25mg (hemi-hepta hydrate); dantrolene sodium hemiheptahydrate 25mg (hemi-hepta hydrate) - capsule - 25 mg - active: dantrolene sodium hemiheptahydrate 25mg (hemi-hepta hydrate) excipient: gelatin ferric oxide e172 (containing ferric oxide, red and ferric oxide, yellow) ink lactose monohydrate magnesium stearate maize starch purified talc sunset yellow fcf titanium dioxide active: dantrolene sodium hemiheptahydrate 25mg (hemi-hepta hydrate) excipient: gelatin ink iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch purified talc sodium laurilsulfate sunset yellow fcf titanium dioxide - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dantrolene sodium hemiheptahydrate 50mg (hemi-hepta hydrate); dantrolene sodium hemiheptahydrate 50mg (hemi-hepta hydrate) - capsule - 50 mg - active: dantrolene sodium hemiheptahydrate 50mg (hemi-hepta hydrate) excipient: gelatin ferric oxide e172 (containing ferric oxide, red and ferric oxide, yellow) ink lactose monohydrate magnesium stearate maize starch purified talc sunset yellow fcf titanium dioxide active: dantrolene sodium hemiheptahydrate 50mg (hemi-hepta hydrate) excipient: gelatin ink iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch purified talc sodium laurilsulfate sunset yellow fcf titanium dioxide - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy.

Малта - Енглески - Malta Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - poloxamer, dantron - oral suspension - poloxamer 188 1000 mg dantron 75 mg - drugs for constipation

Малта - Енглески - Malta Medicines Authority

shire pharmaceutical contracts limited - lanthanum - chewable tablet - lanthanum 250 mg - all other therapeutic products